Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
03/2005
03/03/2005US20050049272 Gastrointestinal disorders; inhibiting gastric acid secretion; such as 2,3-dimethyl-9-(2-ethyl-6-methyl-phenyl)-7H-8,9-dihydro-pyrano[2,3-c]-imidazo[1,2-a]pyridine-6-(N,N-diethyl)carbamide
03/03/2005US20050049264 Suppressing growth of abnormal cells; gastric, brain, colon, pancreatic, lung, renal, ovarian and prostatic cancer
03/03/2005US20050049259 Viricides; for the prophylaxis and treatment of herpes viral infections
03/03/2005US20050049258 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease
03/03/2005US20050049251 Inhibitors of p38
03/03/2005US20050049246 Such as [3-(2-Bromo-ethoxy)-phenyl]-[4-(3-cyclohexyl-5-methyl-isoxazol-4-yl)-pyrimidin-2-yl]-amine
03/03/2005US20050049216 Immunostimulatory nucleic acid molecules
03/03/2005US20050049215 contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulating interferon-alpha to treat viral infections; oligonucleotide linked to a biodegradable delivery complex
03/03/2005US20050049212 Eating disorders, cachexia, diabetes mellitus, hypertension, coronary heart disease, hypercholesterolemia, osteoarthritis, gallstones, cancers of the reproductive organs, and sleep apnea; drug screening; diagnosis and therapy; kits; regulates metabolism of triglycerides
03/03/2005US20050049205 Product from rose hips e.g. 3- beta -D-galactopyranosyloxy-2-(octadeca-9Z,12Z,15Z-trienoyloxy)propanyl octadeca-9Z,12Z,15Z-trienoate (GOPO); arthritis and osteoarthritis
03/03/2005US20050049202 For treating disorders associated with excessive cytokine release such as interleukin-1 (IL-1) for example infection, cancer, asthma, coronary restenosis, autoimmune disease, cirrhosis, entotoxemia, reperfusion injury and septic shock; lactone or lactam-benzoates or benzamides
03/03/2005US20050049190 Cation conducting gabaa receptors and their use
03/03/2005US20050048639 Caspase-8 binding protein, its preparation and use
03/03/2005US20050048528 Using immunoglobulins and diagnostic and/or prognostic tool for detection and treatment of cell proliferative disorders; immunodiagnostics; immunotherapy
03/03/2005US20050048135 Mixture containing plant extract; renin, angiogenesis inhibitor; cardiovascular disorders; antidiabetic agents; liver disorders; gall stones; gastrointestinal disorders
03/03/2005US20050048134 Therapy, prevention of papillomavirus infections; antiinflammatory agents; wound healing agents
03/03/2005US20050048104 Transdermal drug delivery devices comprising a polyurethane drug reservoir
03/03/2005US20050048055 Use of CD40 engagement to alter T cell receptor usage
03/03/2005US20050048043 Methods for in vivo gene transfer into pancreatic and biliary epithelial cells
03/03/2005US20050048035 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
03/03/2005US20050048034 Using adipose stem cells to treat ischemic ulcer, diabetic and traumatic wounds; regenerative medicine
03/03/2005US20050047958 Methods for sterilizing preparations of digestive enzymes
03/03/2005CA2536966A1 Use of enterococcus faecium strains for curing hepatic deficiency and for regenerating and intensifying hepatic metabolism in a liver
03/03/2005CA2536764A1 .alpha.-aminoamide derivatives useful as anti-inflammatory agents
03/03/2005CA2536313A1 Fused pyrimidine derivative and use thereof
03/03/2005CA2535951A1 Bacterial strains, compositions including same and probiotic use thereof
03/03/2005CA2535807A1 Peptides with the capacity to bind to transforming growth factor .beta.1 (tgf-.beta.1)
03/02/2005EP1510580A2 Novel hepatitis C E1 and E2 truncated polypeptides and methods of obtaining the same
03/02/2005EP1510519A1 Pharmaceutical compositions comprising 2,3-diarylpyrazolo[1,5-B]pyridazine derivatives
03/02/2005EP1510518A2 Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha levels
03/02/2005EP1510515A1 Phenylglycine derivatives as serine protease inhibitors
03/02/2005EP1510222A2 Medicinal compositions promoting bowel movement
03/02/2005EP1510214A2 8a-azalides as veterinary antimicrobial agents
03/02/2005EP1510209A1 Therapeutic agent for inflammatory intestinal diseases containing hydroxamic acid compound as active ingredient
03/02/2005EP1510137A1 Pyruvate enriched onion extract
03/02/2005EP1510136A1 Process for producing lacturose-containing powder composition, lacturose-containing powder composition obtained by the process and feed additive
03/02/2005EP1509617A2 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
03/02/2005EP1509549A1 Extraction of unmilled psyllium
03/02/2005EP1509532A1 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
03/02/2005EP1509528A2 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
03/02/2005EP1509526A2 Imidazo(1,2-a)pyrazin-8-ylamines, method of making, and method of use thereof
03/02/2005EP1509515A2 Substituted 4-aryl-4h-pyrrolo 2,3-h chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
03/02/2005EP1509506A1 Pyridazine derivatives
03/02/2005EP1509504A1 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents
03/02/2005EP1509498A1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
03/02/2005EP1509489A1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
03/02/2005EP1509285A2 Synergistic composition of trans-tetracos-15-enoic acid and apocynin and use thereof
03/02/2005EP1509251A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
03/02/2005EP1509249A2 Inclusion complexes of rosiglitazone
03/02/2005EP1509242A1 Treatment of hepatitis c in the asian population with subcutaneous interferonbeta
03/02/2005EP1509234A1 Treatment of mucositis
03/02/2005EP1509233A1 Liquid formulation of decitabine and use of the same
03/02/2005EP1509227A1 A buffered, liquid nicotine composition for pulmonary administration
03/02/2005EP1509223A1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin
03/02/2005EP1509188A2 Compounds active at the glucocorticoid receptor ii
03/02/2005EP1435998A4 Method for treating hepatitis c virus infection in treatment failure patients
03/02/2005EP1296650B1 Methods and compositions for treating pain of the mucous membrane
03/02/2005EP1244649B1 Cyclic amp-specific phosphodiesterase inhibitors
03/02/2005EP1238979B1 Fused heterotricyclic compounds, process for preparing the compounds and drugs containing the same
03/02/2005EP1109532B1 Oral micro-emulsion composition of silybin
03/02/2005EP1086082B9 Arylsubstituted olefinic amines and their use as cholinergic receptors agonists
03/02/2005EP1014976B1 Novel substituted imidazole compounds
03/02/2005EP0983079B1 A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
03/02/2005EP0824530B1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
03/02/2005CN1589273A The use of anti-histaminics for acute reduction of elevated intracranial pressure
03/02/2005CN1589271A Fused heterocyclic succinimide compounds and analogs thereof as modulators of nuclear hormone receptor function
03/02/2005CN1589269A Heteroindanes: a new class of potent cannabimimetic ligands
03/02/2005CN1589268A Substituted benzopyrans compounds as selective estrogen receptor-beta agonists
03/02/2005CN1589261A Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5)
03/02/2005CN1589260A Heterocyclic compounds and methods of use thereof
03/02/2005CN1589258A Novel beta -phenyl- alpha -oxysubstituted propionic derivatives: process for their preparation and their use in the preparation of pharmaceutically important compounds
03/02/2005CN1589156A Preparation compositions containing acid-unstable physiologically active compounds and process for producing the same
03/02/2005CN1589151A Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
03/02/2005CN1589148A Succinic acid salts of 5, 8, 14-triazatetracyclo'10.3.1.0 less than2, 11greater than.0 less than 4, 9 greater than-hexadeca-2(11), 3, 5, 7, 9-pentaene and pharmaceutical compositions thereof
03/02/2005CN1589136A Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes
03/02/2005CN1587408A Structure of anti-hypatitis B virus antisense oligonucleotide of target de-sialoglycoprotein receptor
03/02/2005CN1586617A Medicine for treating hepatitis B
03/02/2005CN1586611A Preparation of granular powder for treating hepatitis and quality control method
03/02/2005CN1586602A Medicinal composition for treating cholelithiasis and its preparing method
03/02/2005CN1586601A Coupling agent for external stone crushing and its preparing method
03/02/2005CN1586600A Tibet medicine lamivphlomis root injection preparation and its preparing method
03/02/2005CN1586597A Ginseng oral disintegration tablet and its preparing process
03/02/2005CN1586596A American ginseng and its extract oral disintegration tablet and its preparing process
03/02/2005CN1586595A Wuju tea
03/02/2005CN1586592A Chinese medicine health preparation
03/02/2005CN1586578A Pill for nourishing stomach and strengthening spleen
03/02/2005CN1586569A Oral health liquid
03/02/2005CN1586546A Medicine for treating liver and biliary diseases and its preparing method
03/02/2005CN1586540A Zhenge lozenge having sobering, liver protection and stomach protection health function
03/02/2005CN1586537A Chinese medicine pill for strengthening spleen and reinforcing stomach
03/02/2005CN1586536A Composition having liver disease treating function and its preparing method
03/02/2005CN1586535A Liuweidihuang effervescent tablet and its preparing method
03/02/2005CN1586518A Method for preparing injection for treating urinary inflection and enteritis of livestock
03/02/2005CN1586512A Medicine for treating liver disease
03/02/2005CN1586502A Process for preparing compound coemzyme medicine and its compound coemzyme medicine and clinical use
03/02/2005CN1586496A Baicalin soft capsule and its preparing method
03/02/2005CN1586490A Compound glycyrrhizunate tablet and its preparing method
03/02/2005CN1586489A Compound glycyrrhizunate capsule and particles and the preparing method
03/02/2005CN1586488A Chitosan glycyrrhizic acid nano particle and its preparing method
03/02/2005CN1586487A Glycyrrhizin triple composition nano micro particle and its preparing method
1 ... 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 ... 1258